tiprankstipranks
GSK unit ordered to pay AstraZeneca royalties on Zejula sales, Reuters says
The Fly

GSK unit ordered to pay AstraZeneca royalties on Zejula sales, Reuters says

A U.K. court has determeind that GSK‘s (GSK) Tesaro will have to pay AstraZeneca (AZN) royalties on total sales of ovarian cancer treatment Zejula, Reuters’ Sinchita Mitra, Ahy Koilparambil, and Yadarisa Shabong report. Tesaro had claimed the royalty was payable only on sales for users claimed or covered by the licensed patents, the authors note. Reference Link

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on GSK:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles